Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027. Novo Nordisk's blockbuster diabetes drug ...

In 2023, Medicare selected 10 drugs for its first round of price negotiations. Agreements were reached with drug manufacturers to establish new, reduced prices for all 10 drugs. These prices ...

The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...

The executive order was the largest action to date by the second Trump administration on prescription drug costs but experts ...

CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...

President Trump on Monday called on drugmakers to lower their prices within the next month to be closer to those charged in ...

"Some prescription drugs and pharmaceutical prices will be reduced almost immediately by 50 to 80 to 90%," said Trump. This would apply to commercial and Medicare ... cuts down the price to ...

Why It Matters: This move is expected to have the biggest impact on Medicare Part B drugs, which mainly constitute ... if the President cannot force price cuts. Novo Nordisk shares have an ...

Such a change has the potential to increase costs for the government, because it would most likely delay the existing timetable for some drugs to become eligible for Medicare price cuts.

May 12 (Reuters) - The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible for a third round of Medicare price negotiations by ...